Search

Chunfeng Yin

from Redmond, WA
Age ~61
Get Report
Also known as:
Chunfeng Yen, Feng Yin Chun
Related to:
Hao Wang, 46Shougang Wang, 48Dennis A Schlossberg, 66Man Ho Chun, 44Thomas H Liu, 89Jen Wang ChunChunchao YinShuet C Ho, 75Cj Wang
Connected to:
Alice C Yin, 67Angela H Yin, 42Anita Yin, 51Boqun Yin, 40Calvin Yin, 31Cathy L Yin, 71Chu C Yin, 71Chunkai Yin, 50Connie K Yin, 52Daniel H Yin, 52

Chunfeng Yin Phones & Addresses

  • Redmond, WA
  • Winchester, CA
  • 3585 Caminito El Rincon, San Diego, CA 92130 (858) 847-0859
  • Lexington, KY

Publications

Us Patents

3-Amido-Pyrrolo[3,4-C]Pyrazole-5(1H,4H,6H) Carbaldehyde Derivatives

View page
US Patent:
8114871, Feb 14, 2012
Filed:
Apr 10, 2008
Appl. No.:
12/532051
Inventors:
Iriny Botrous - San Diego CA, US
Yufeng Hong - San Diego CA, US
Hui Li - Carlsbad CA, US
Kevin Kun-Chin Liu - San Marcos CA, US
Seiji Nukui - San Diego CA, US
Min Teng - San Diego CA, US
Eileen Valenzuela Tompkins - Escondido CA, US
Chunfeng Yin - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 31/535
A61K 31/495
A61K 31/497
A61K 31/4965
C07D 413/14
C07D 237/00
C07D 239/00
C07D 403/14
C07D 241/36
C07D 401/14
US Classification:
5142342, 514249, 51425309, 51425406, 514250, 51425506, 544121, 544230, 544231, 544282, 544295, 544344, 544349, 544363, 544371
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formula (I): wherein X, R, R, R, R, R, R, R, and Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications (including in particular diabetic retinopathy, nephropathy or neuropathy), cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, viral diseases, inflammatory disorders, or diseases in which the liver is a target organ.

N-Pyrimidin-4-Yl-3-Amino-Pyrrolo[3,4-C]Pyrazole Derivatives As Pkc Kinase Inhibitors

View page
US Patent:
8183255, May 22, 2012
Filed:
Feb 4, 2008
Appl. No.:
12/523965
Inventors:
Hui Li - Carlsbad CA, US
Seiji Nukui - San Diego CA, US
Stephanie Anne Scales - San Diego CA, US
Min Teng - San Diego CA, US
Chunfeng Yin - San Diego CA, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 31/505
US Classification:
514275, 544324, 544386, 546245, 5483605, 549356
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formulas A and B: (A) and (B) wherein A, B, R, R, R, R, R, R, R, R, Rand Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.

Inhibitors Of The Hiv Integrase Enzyme

View page
US Patent:
20050277662, Dec 15, 2005
Filed:
Apr 25, 2005
Appl. No.:
11/115003
Inventors:
Klaus Dress - San Diego CA, US
Qiyue Hu - Carlsbad CA, US
Ted Johnson - San Clemente CA, US
Michael Plewe - San Diego CA, US
Steven Tanis - Carlsbad CA, US
Hai Wang - San Diego CA, US
Anle Yang - San Diego CA, US
Chunfeng Yin - San Diego CA, US
Junhu Zhang - San Diego CA, US
International Classification:
A61K031/4745
C07D471/02
US Classification:
514300000, 546113000
Abstract:
The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

Novel 3-Amido-Pyrrolo[3,4-C]Pyrazole-5(1H, 4H,6H) Carbaldehyde Derivatives

View page
US Patent:
20120108588, May 3, 2012
Filed:
Jan 6, 2012
Appl. No.:
13/345528
Inventors:
Iriny Botrous - San Diego CA, US
Yufeng Hong - San Diego CA, US
Hui Li - Carlsbad CA, US
Kevin Kun-Chin Liu - San Marcos CA, US
Seiji Nukui - San Diego CA, US
Min Teng - San Diego CA, US
Eileen Valenzuela Tompkins - Escondido CA, US
Chunfeng Yin - San Diego CA, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 31/5377
A61K 31/4985
A61K 31/499
A61K 31/496
A61K 31/506
A61P 3/10
A61P 35/00
A61P 9/10
A61P 29/00
A61P 25/00
A61P 9/00
A61P 25/28
A61P 17/00
A61P 31/12
A61P 1/16
C07D 487/04
US Classification:
5142342, 544349, 544231, 544371, 544364, 544295, 544282, 544367, 544121, 514249, 51425309, 51425406, 51425404, 51425219, 51425211
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formula (I):wherein X, R, R, R, R, R, R, R, and Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications (including in particular diabetic retinopathy, nephropathy or neuropathy), cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, viral diseases, inflammatory disorders, or diseases in which the liver is a target organ.

Novel N-Pyrimidin-4-Yl-3-Amino-Pyrrolo[3,4-C]Pyrazole Derivatives As Pkc Kinase Inhibitors

View page
US Patent:
20120202809, Aug 9, 2012
Filed:
Apr 18, 2012
Appl. No.:
13/450388
Inventors:
Hui Li - Carlsbad CA, US
Seiji Nukui - San Diego CA, US
Stephanie Anne Scales - San Diego CA, US
Min Teng - San Diego CA, US
Chunfeng Yin - San Diego CA, US
International Classification:
A61K 31/5377
A61K 31/506
A61K 31/4985
A61K 31/4545
A61K 31/496
A61P 3/10
A61P 35/00
A61P 9/10
A61P 29/00
A61P 25/00
A61P 9/00
A61P 25/28
A61P 17/00
A61P 31/12
A61P 1/16
A61P 13/12
A61P 27/02
C07D 487/04
US Classification:
5142342, 544295, 51425219, 544231, 514249, 544121, 544324, 514275, 544328, 514256, 546193, 514318, 544364, 51425309, 544349, 544317, 514274
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formulas A and B:wherein A, B, R, R, R, R, R, R, R, R, Rand Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disase pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.

Polymer Conjugates With A Linker

View page
US Patent:
20130295039, Nov 7, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/791137
Inventors:
- Osaka, JP
Kwok Yin Tsang - Irvine CA, US
Chunfeng Yin - San Diego CA, US
Yi Jin - Carlsbad CA, US
Lei Yu - Carlsbad CA, US
Assignee:
NITTO DENKO CORPORATION - Osaka
International Classification:
A61K 47/48
US Classification:
424 7817, 525432
Abstract:
This application relates generally to biocompatible water-soluble polymers with pendant functional groups and methods for making them, and particularly to polyglutamate amino acid conjugates that can include a linker to a compound that can include a drug, and their use for a variety of drug delivery applications, e.g., anticancer.

Conjugates Of Cartilage-Homing Peptides

View page
US Patent:
20210252159, Aug 19, 2021
Filed:
Apr 19, 2019
Appl. No.:
17/049148
Inventors:
- Seattle WA, US
Julian A. SIMON - Seattle WA, US
Chunfeng YIN - Redmond WA, US
Christopher MEHLIN - Seattle WA, US
Michelle L. COOK SANGAR - Kenmore WA, US
Andrew James MHYRE - Kenmore WA, US
Joseph Michael BEATY - Seattle WA, US
James OLSON - Seattle WA, US
International Classification:
A61K 47/64
A61K 47/54
A61K 31/573
A61K 31/58
A61P 19/02
A61P 37/06
Abstract:
Compositions such as pharmaceutical compositions and uses for peptide-drug conjugates are disclosed. Such compositions can deliver a drug, a peptide, or a conjugate thereof to a target region, tissue, structure or cell in cartilage.

Novel 3-Amino-Pyrrolo[3,4-C]Pyrazole-5(1H, 4H,6H) Carbaldehyde Derivatives

View page
US Patent:
20200002359, Jan 2, 2020
Filed:
Apr 17, 2019
Appl. No.:
16/387369
Inventors:
- New York NY, US
Seiji NUKUI - San Diego CA, US
Stephanie Anne SCALES - San Diego CA, US
Min TENG - San Diego CA, US
Chunfeng YIN - San Diego CA, US
International Classification:
C07D 519/00
C07D 487/04
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formulas A and B:wherein A, B, R, R, R, R, R, R, R, R, Rand Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.
Control profile
Chunfeng Yin from Redmond, WA, age ~61 Get Report